NCT06985485
- Conditions
- Acute Lymphoblastic Leukemia, Blinatumomab, Hematologic Diseases, +12 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Blinatumomab
Explore clinical trials studying Blinatumomab. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Blinatumomab trial results
NCT06789107
- Conditions
- Autoimmune Diseases, Blinatumomab, Children, +5 more
- Locations
-
- Children's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
- Children's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Not Yet Recruiting
A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
NCT07283640
- Conditions
- Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- MD Anderson Cancer Houston, Texas, United States
NCT07178912
- Conditions
- Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Not Yet Recruiting
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
NCT07192237
- Conditions
- Acute Lymphoblastic Leukemia, Blinatumomab, Hematologic Diseases, +11 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States